LNGR


Longevity Thematic ETF

Fund Summary

The Global X Longevity Thematic ETF (LNGR) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Longevity Thematic ETF (LNGR) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.

Why LNGR?

High Growth Potential

LNGR enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

LNGR's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, LNGR delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 02/25/21

Key Facts

Ticker LNGR
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 99

Stats & Fees

Net Assets $40,782,511
Net Asset Value (NAV) $28.13
Shares Outstanding 1,450,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.48%
Distribution Frequency Semi-Annually

Fund Prices As of 02/25/21

NAV $28.13 Daily Change -$0.30 -1.05%
Market Price $28.03 Daily Change -$0.57 -1.99%
30-Day Median Bid-Ask Spread 0.24%

Performance History

As of recent
(12/31/20)
As of recent
(12/31/20)
Fund NAV Market Price Index
1 Year 19.28% 18.96% 19.60%
3 Years 13.97% 13.69% 14.21%
Since Inception 14.96% 15.39% 15.27%
1 Year 20.90% 20.87% 21.27%
3 Years 11.38% 11.49% 11.62%
Since Inception 14.75% 15.34% 15.06%
Year-to-Date 19.28% 18.96% 19.60%
1 Month 4.68% 4.19% 4.73%
3 Months 9.41% 9.06% 9.53%
Since Inception 91.01% 94.34% 93.61%
Year-to-Date 0.32% 1.00% 0.35%
1 Month 0.32% 1.00% 0.35%
3 Months 14.91% 15.38% 15.02%
Since Inception 91.63% 96.29% 94.29%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 02/24/21

Return on Equity 12.80%
Weighted Avg. Market Cap 40,776 M
2020 2021
Price-to-earnings 33.37 28.35
Price-to-book value 3.80 3.47

Source: AltaVista Research, LLC

Fund Risk Stats As of 02/24/21

Versus Beta
S&P 500 0.85
MSCI EAFE 0.78
MSCI Emg. Mkts 0.64
Standard Deviation 18.30%

Source: AltaVista Research, LLC

Sector Breakdown As of 01/31/21

% of Net Assets
Health Care 93.2
Real Estate 4.9
Information Technology 0.8
Consumer Discretionary 0.4
Industrials 0.3
Other/Cash 0.4

Source: AltaVista Research, LLC

Country Breakdown As of 01/31/21

% of Net Assets
United States 59.7
Denmark 6.4
Japan 6.1
Switzerland 5.2
China 4.5
Ireland 3.1
Britain 3.1
South Korea 2.9
France 2.2
Germany 1.7
Belgium 1.4
Other/Cash 3.7

Source: AltaVista Research, LLC

Top Holdings As of 02/26/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.18 ALGN ALIGN TECHNOLOGY INC 2679204 567.11 2,261 1,282,235.71
3.16 SYK STRYKER CORP 2853688 242.69 5,235 1,270,482.15
3.15 ABBV ABBVIE INC B92SR70 107.74 11,764 1,267,453.36
2.78 NOVOB DC NOVO NORDISK A/S-B BHC8X90 71.49 15,635 1,117,706.30
2.76 EW EDWARDS LIFESCIENCES CORP 2567116 83.10 13,381 1,111,961.10
2.70 MDT MEDTRONIC PLC BTN1Y11 116.97 9,304 1,088,288.88
2.60 068270 KS CELLTRION INC B0C5YV1 264.80 3,949 1,045,627.10
2.59 DXCM DEXCOM INC B0796X4 397.78 2,617 1,040,990.26
2.53 BSX BOSTON SCIENTIFIC CORP 2113434 38.78 26,300 1,019,914.00
2.44 4519 JP CHUGAI PHARMA CO 6196408 44.71 22,018 984,341.41
2.42 BMY BRISTOL-MYERS SQUIBB CO 2126335 61.33 15,863 972,877.79
2.41 ALC SW ALCON INC BJT1GR5 69.08 14,035 969,566.88
2.40 ZBH ZIMMER BIOMET HO 2783815 163.06 5,930 966,945.80
2.37 AMGN AMGEN INC 2023607 224.92 4,248 955,460.16
2.23 BDX BECTON DICKINSON AND CO 2087807 241.15 3,726 898,524.90
2.10 3692 HK HANSOH PHARMACEU BJYKB72 5.09 165,900 844,753.69
2.02 REGN REGENERON PHARMACEUTICALS 2730190 450.57 1,805 813,278.85
2.01 4543 JP TERUMO CORP 6885074 37.08 21,776 807,555.62
1.99 WELL WELLTOWER INC BYVYHH4 67.90 11,785 800,201.50
1.97 BIIB BIOGEN INC 2455965 272.88 2,912 794,626.56
1.95 VRTX VERTEX PHARM 2931034 212.55 3,698 786,009.90
1.87 SGEN SEAGEN INC BLPK4D2 151.11 4,993 754,492.23
1.76 BGNE BEIGENE LTD-ADR BYYWPW6 320.00 2,214 708,480.00
1.57 GMAB DC GENMAB A/S 4595739 337.89 1,867 630,841.05
1.51 FME GR FRESENIUS MEDICA 5129074 69.62 8,723 607,325.61
1.45 EXAS EXACT SCIENCES CORP 2719951 136.12 4,302 585,588.24
1.41 VTR VENTAS INC 2927925 52.90 10,700 566,030.00
1.39 UCB BB UCB SA 5596991 100.07 5,580 558,365.74
1.36 STMN SW STRAUMANN HOLDING AG-REG 7156832 1,213.96 451 547,496.96
1.22 INCY INCYTE CORP 2471950 78.66 6,220 489,265.20
1.20 SN/ LN SMITH & NEPHEW PLC 0922320 19.37 24,903 482,385.52
1.19 SOON SW SONOVA HOLDING AG-REG 7156036 257.15 1,859 478,046.17
1.15 PODD INSULET CORP B1XGNW4 259.10 1,784 462,234.40
1.13 VAR VARIAN MEDICAL S 2927516 175.27 2,604 456,403.08
1.10 DGX QUEST DIAGNOSTICS INC 2702791 115.59 3,830 442,709.70
1.08 BIM FP BIOMERIEUX BF0LBX7 127.69 3,397 433,768.36
1.08 NVCR NOVOCURE LTD BYSS4X4 149.10 2,906 433,284.60
1.04 ABMD ABIOMED INC 2003698 324.55 1,295 420,292.25
0.91 DVA DAVITA INC 2898087 102.13 3,593 366,953.09
0.85 GN DC GN STORE NORD A/S 4501093 84.55 4,065 343,712.71
0.84 XRAY DENTSPLY SIRONA INC BYNPPC6 53.07 6,343 336,623.01
0.75 COH AU COCHLEAR LTD 6211798 163.67 1,835 300,340.14
0.72 DEMANT DC DEMANT A/S BZ01RF1 41.44 7,013 290,651.00
0.72 NBIX NEUROCRINE BIOSC 2623911 109.51 2,637 288,777.87
0.70 PNTG PENNANT GROUP INC/THE BKTC976 52.78 5,320 280,789.60
0.66 GKOS GLAUKOS CORP BYMWL19 94.56 2,828 267,415.68
0.65 SAGE SAGE THERAPEUTICS INC BP4GNK9 85.00 3,068 260,780.00
0.64 AMP IM AMPLIFON SPA B14NJ71 40.06 6,458 258,677.45
0.59 OHI OMEGA HEALTHCARE 2043274 37.14 6,408 237,993.12
0.59 HALO HALOZYME THERAPEUTICS INC 2975098 45.25 5,208 235,662.00
0.58 AMED AMEDISYS INC 2024332 253.64 927 235,124.28
0.56 ORP FP ORPEA 7339451 120.75 1,853 223,747.29
0.55 LUN DC H LUNDBECK A/S 7085259 38.31 5,731 219,557.76
0.54 ACAD ACADIA PHARMACEU 2713317 48.97 4,444 217,622.68
0.54 PHM SM PHARMA MAR SA BMW2GT8 133.03 1,633 217,241.76
0.54 NVST ENVISTA HOLDINGS CORP BK63SF3 38.54 5,614 216,363.56
0.52 IONS IONIS PHARMACEUTICALS INC BDJ0LS6 52.40 3,995 209,338.00
0.51 ENSG ENSIGN GROUP INC/THE B1YWPP8 82.02 2,483 203,655.66
0.49 MYGN MYRIAD GENETICS INC 2614153 30.49 6,457 196,873.93
0.47 EXEL EXELIXIS INC 2576941 21.66 8,752 189,568.32
0.43 MOVE SW MEDACTA GROUP SA BJYLTQ0 114.44 1,522 174,173.42
0.42 BKD BROOKDALE SR B0PZN33 5.82 28,960 168,547.20
0.41 IART INTEGRA LIFESCIE 2248693 68.34 2,422 165,519.48
0.41 LHCG LHC GROUP INC B06DT50 181.71 902 163,902.42
0.38 MMSI MERIT MEDICAL SYSTEMS INC 2580555 55.72 2,754 153,452.88
0.38 RYM NZ RYMAN HEALTHCARE LTD 6161525 10.65 14,351 152,866.69
0.37 LIVN LIVANOVA PLC BYMT0J1 77.54 1,913 148,334.02
0.37 BPMC BLUEPRINT MEDICINES CORP BWY52P3 98.22 1,499 147,231.78
0.35 EKTAB SS ELEKTA AB-B SHS B0M42T2 13.55 10,491 142,188.83
0.35 SILK SILK ROAD MEDICAL INC BGHVXJ7 54.77 2,570 140,758.90
0.34 DHC DIVERSIFIED HEAL BKRN595 4.50 30,570 137,565.00
0.34 4544 JP H.U. GROUP HOLDINGS INC 6356611 30.93 4,402 136,142.20
0.34 RDUS RADIUS HEALTH INC BM68KK1 18.61 7,315 136,132.15
0.33 ATT SS ATTENDO AB BZ1N262 5.51 23,781 130,963.81
0.32 KORI FP KORIAN B1HKRM0 34.96 3,665 128,118.86
0.32 FGEN FIBROGEN INC BSDRYR8 50.03 2,548 127,476.44
0.32 ITGR INTEGER HOLDINGS CORP BD06LM7 88.19 1,445 127,434.55
0.32 SBRA SABRA HEALTH CAR B5NLBP6 17.22 7,396 127,359.12
0.31 AERI AERIE PHARMACEUTICALS INC BFRTDG1 18.39 6,879 126,504.81
0.31 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.68 185,847 125,537.49
0.31 2500 HK VENUS MEDTECH -H BL6V047 8.86 14,000 123,985.64
0.31 CASH 1.00 123,188 123,198.35
0.29 CSH-U CN CHARTWELL RETIRE B8S8C94 8.65 13,649 118,054.15
0.29 NHI NATL HEALTH INVESTORS INC 2626125 68.27 1,727 117,902.29
0.28 LTC LTC PROPERTIES INC 2498788 40.91 2,742 112,175.22
0.28 ALKS ALKERMES PLC B3P6D26 19.04 5,817 110,755.68
0.27 8086 JP NIPRO CORP 6641599 12.42 8,675 107,725.03
0.27 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 47.44 2,255 106,977.20
0.27 AMRN AMARIN CORP PLC -ADR 2301938 6.74 15,856 106,869.44
0.26 NUVA NUVASIVE INC B00GJC2 60.33 1,705 102,862.65
0.26 TCMD TACTILE SYSTEMS BZB1XF2 50.82 2,022 102,758.04
0.24 NTUS NATUS MEDICAL INC 2771133 25.91 3,761 97,447.51
0.23 INGN INOGEN INC BJSVLL5 52.49 1,792 94,062.08
0.22 4534 JP MOCHIDA PHARMACEUTICAL CO 6598004 37.17 2,370 88,090.86
0.20 NHC NATIONAL HEALTHCARE CORP 2139731 69.55 1,182 82,208.10
0.19 4547 JP KISSEI PHARM CO 6494061 19.92 3,873 77,140.10
0.19 8129 JP TOHO HOLDINGS CO LTD 6895556 17.28 4,313 74,528.19
0.17 BLUE BLUEBIRD BIO INC BBFL7S1 31.10 2,142 66,616.20
0.13 EPZM EPIZYME INC B9Z1QZ7 9.59 5,471 52,466.89
0.13 084990 KS HELIXMITH CO LTD B0P5XC2 21.45 2,370 50,838.45
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of companies in which LNGR may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. LNGR is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.